Author Archive: Daniel Seaton

Daniel Seaton

Daniel Seaton is Manager of Event & Health Communications, working on communications for BIO’s events and health care policy issues. Prior to joining BIO in August 2013, he spent four years in communications at the Pharmaceutical Research and Manufacturers of America. The best part of his job is educating audiences about the many benefits the bioscience industry produces for patients, consumers, and the economy as a whole. Daniel enjoys hiking, camping, and, when he can find a game, playing bridge. Having grown up in New Mexico, one of his favorite foods is roasted green chile. He is currently finishing up a Master’s degree in communications at Georgetown University.

Latest Posts

FierceBiotech Names 2014 Fierce 15

FierceBiotech

FierceBiotech released their much-anticipated 2014 Fierce 15 list today, their annual list of private biotech upstarts to watch. We’ll be hearing from three of them at next month’s BIO Investor Forum, October 7-8 in San Francisco: Adaptimmune and Sutro Biopharma will be making company presentations, and Editas Medicine CEO Katrine Bosley will participate as a panelist in one of our therapeutic workshops, Gene Therapy Ascending? Today’s Advancements Over Past Hurdles. Here’s the scoop on each, Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Jim Greenwood: Biopharma Answers the Call for Cures

jim-gw

Recently, BIO President and CEO Jim Greenwood participated in a roundtable hosted by Congressman Joe Pitts (PA-16) to discuss new ways to expedite new cures for patients in need. C-SPAN covered the event, which may be viewed below:    Yesterday The Hill published an op-ed by Jim which spells out in more detail one of BIO’s proposals to accelerate new cures and treatments: I propose the development and execution of a large-scale, longitudinal study to Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Participating in IDSA Stakeholder Group on Antimicrobial Resistance

MRSA

BIO will be participating in a newly formed partnership which will work collaboratively to inform federal policy and find ways to better combat the growing crisis of antimicrobial resistance. Launched yesterday by the Infectious Diseases Society of America (IDSA), which also released foundation principles for the group, the U.S. Stakeholder Forum on Antimicrobial Resistance (S-FAR) will hold its inaugural meeting in Philadelphia next month on October 9th. BIO joins more than 75 other national organizations Read More >

Health, Public Policy  |  1 Comment  |  Email This Post
Tags: , , , ,

Tackling the Thorny Problem of Alzheimer’s

football1

Football fans are gearing up for tonight’s opening game when the defending Champion Seattle Seahawks take on the Green Bay Packers, and last minute fantasy leaguers are scrambling to finish their drafts and set their starting line-ups. The NFL has also been in the news recently following preliminary approval of a deal in the class-action lawsuit to compensate former players for concussion-related injury claims. According to a 2012 study in Neurology, NFL players are three Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

The New Republic: We are Entering the Age of Alzheimer’s

alzheimers

The New Republic this week published a lengthy, powerful piece by Kent Russell on Alzheimer’s. Russell opens the piece by noting that we are approaching a public health crisis in Alzheimer’s and dementia: Alzheimer’s disease is practically unheard of in adults younger than 40, and very rare (one in 2,500) for those under 60. It affects 1 percent of 65-year-olds, 2 percent of 68-year-olds, 3 percent of 70-year-olds. After that, the odds start multiplying. The Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,